MIRA Pharmaceuticals, Inc. (MIRA) Stock Forecast & Price Target
MIRA Analyst Ratings
MIRA Stock 12 Month Forecast
Average Price Target
$3.50▲(538.69% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | Maxim Group | $3.50 | buy | 538.69%Upside | Reiterated | 10/22/26 | ||
| Michael King | Rodman & Renshaw | $8 | buy | 1359.85%Upside | Initiated | 01/13/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | 10/22/26 | $3.50 | buy | 538.69%Upside | Reiterated | Maxim Group | ||
| Michael King | 01/13/26 | $8 | buy | 1359.85%Upside | Initiated | Rodman & Renshaw |
Best Analysts Covering MIRA Pharmaceuticals, Inc.
Copying Jason McCarthy's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -20.20% per trade.
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -20.20% per trade.
Copying Jason McCarthy's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -20.20% per trade.
MIRA Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 1 | 2 | 2 |
In the current month, MIRA has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MIRA average Analyst price target in the past 3 months is 3.50.
MIRA Financial Forecast
MIRA Earnings Forecast
Next quarter’s earnings estimate for MIRA is -$0.48 with a range of ― to ―. The previous quarter’s EPS was ―. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.